Cardiovascular risk markers in hypothalamic amenorrhoea.
OBJECTIVE
To determine whether women with oestrogen deficiency due to hypothalamic amenorrhoea (HA) would demonstrate a lipid and lipoprotein pattern similar to that seen in menopause with higher total cholesterol (TC), LDL, triglyceride and Lp(a) and lower HDL levels than women with regular menstrual cycles.


METHODS
Cross-sectional.


METHODS
Fifty subjects: 21 women with HA and 30 eumenorrhoeic controls (NL) matched for age, BMI and fat-free mass.


METHODS
Lipid and lipoprotein levels.


RESULTS
There was a significant difference in Lp(a) levels in the HA group between women with >19% fat intake and those <19% fat intake (352+/-231 vs. 116+/-62 mg/l, P = 0.006). Percent fat intake was the most significant determinant of Lp(a) levels in HA, accounting for 51% of the variation in Lp(a) levels. Mean HDL levels were higher in the women with HA compared with the controls (1.3+/- 0.3 vs. 1.1+/-0.2 mmol/l, P = 0.002). There was no significant difference between the groups in TC [4.4+/-0.9 (HA) vs. 4.1+/-0.8 mmol/l (NL), P>0.05], LDL [2.8+/-0.6 (HA) vs. 2.7+/-0.7 mmol/l (NL), P>0.05], triglycerides [1.8+/-0.5 (HA) vs. 1.7+/-0.5 mmol/l (NL), P>0.05] or Lp(a) [234+/-199 (HA) vs. 247+/-222 (NL) mg/l, P>0.05] levels.


CONCLUSIONS
Reduced Lp(a) levels were associated with low dietary fat in women with HA. Moreover, in contrast to menopausal oestrogen deficiency, young women with HA and oestrogen deficiency have increased levels of HDL and no increases in TC, LDL and triglycerides. These data suggest that the negative effects of oestrogen deficiency on cardiovascular risk factors may be modified in women with hypothalamic amenorrhoea.
Miller
K K
KK
Neuroendocrine Unit, Department of Medicine and Clinical Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Grinspoon
S
S
Klibanski
A
A
D000328:Adult; D000568:Amenorrhea / Q000097:blood / Q000209:etiology*; D002318:Cardiovascular Diseases / Q000209:etiology; D016022:Case-Control Studies; D002784:Cholesterol / Q000097:blood; D003430:Cross-Sectional Studies; D004041:Dietary Fats / Q000008:administration & dosage; D004967:Estrogens / Q000172:deficiency*; D005260:Female; D006801:Humans; D007027:Hypothalamic Diseases / Q000097:blood / Q000150:complications*; D008055:Lipids / Q000097:blood*; D017270:Lipoprotein(a) / Q000097:blood; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood
D004041:Dietary Fats; D004967:Estrogens; D008055:Lipids; D017270:Lipoprotein(a); D014280:Triglycerides; D002784:Cholesterol